Medicamen Biotech has informed that in pursuance of the Company’s Code of Conduct for prevention of Insider Trading in terms of SEBI (Prohibition of Insider Trading) Regulations and Code of Practices and Procedure for fair disclosure of Unpublished Price Sensitive Information, the trading window for dealing in the securities of the Company for all the Designated Persons, has been closed from October 1, 2019 till the expiry of 48 hours after the un-audited financial results for the 2nd quarter ending on September 30, 2019 become generally available information. The date of Board Meeting for the aforesaid purpose will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
